Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12599241rdf:typepubmed:Citationlld:pubmed
pubmed-article:12599241lifeskim:mentionsumls-concept:C0678222lld:lifeskim
pubmed-article:12599241lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12599241lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:12599241lifeskim:mentionsumls-concept:C0086589lld:lifeskim
pubmed-article:12599241lifeskim:mentionsumls-concept:C1708250lld:lifeskim
pubmed-article:12599241lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:12599241lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:12599241lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:12599241lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:12599241lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:12599241pubmed:issue5lld:pubmed
pubmed-article:12599241pubmed:dateCreated2003-2-24lld:pubmed
pubmed-article:12599241pubmed:abstractTextThe number of mitoses and, thus, the proliferative capacity of a tumor is one of the most crucial variables for tumor grading. The Ki-67 nuclear antigen may be considered as an alternative to mitotic counts in grading schemes and as a single parameter that can be used in fine-needle aspirates and small biopsies.lld:pubmed
pubmed-article:12599241pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12599241pubmed:languageenglld:pubmed
pubmed-article:12599241pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12599241pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12599241pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12599241pubmed:statusMEDLINElld:pubmed
pubmed-article:12599241pubmed:monthMarlld:pubmed
pubmed-article:12599241pubmed:issn0008-543Xlld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:International...lld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:GelberRichard...lld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:MurraySusanSlld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:GustersonBarr...lld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:GoldhirschAro...lld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:Castiglione-G...lld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:CollinsJohnJlld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:GolouhRastkoRlld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:CoatesAlan...lld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:PriceKarenKlld:pubmed
pubmed-article:12599241pubmed:authorpubmed-author:TrihiaHelenHlld:pubmed
pubmed-article:12599241pubmed:copyrightInfoCopyright 2003 American Cancer Society.lld:pubmed
pubmed-article:12599241pubmed:issnTypePrintlld:pubmed
pubmed-article:12599241pubmed:day1lld:pubmed
pubmed-article:12599241pubmed:volume97lld:pubmed
pubmed-article:12599241pubmed:ownerNLMlld:pubmed
pubmed-article:12599241pubmed:authorsCompleteYlld:pubmed
pubmed-article:12599241pubmed:pagination1321-31lld:pubmed
pubmed-article:12599241pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12599241pubmed:meshHeadingpubmed-meshheading:12599241...lld:pubmed
pubmed-article:12599241pubmed:meshHeadingpubmed-meshheading:12599241...lld:pubmed
pubmed-article:12599241pubmed:meshHeadingpubmed-meshheading:12599241...lld:pubmed
pubmed-article:12599241pubmed:meshHeadingpubmed-meshheading:12599241...lld:pubmed
pubmed-article:12599241pubmed:meshHeadingpubmed-meshheading:12599241...lld:pubmed
pubmed-article:12599241pubmed:meshHeadingpubmed-meshheading:12599241...lld:pubmed
pubmed-article:12599241pubmed:meshHeadingpubmed-meshheading:12599241...lld:pubmed
pubmed-article:12599241pubmed:meshHeadingpubmed-meshheading:12599241...lld:pubmed
pubmed-article:12599241pubmed:meshHeadingpubmed-meshheading:12599241...lld:pubmed
pubmed-article:12599241pubmed:year2003lld:pubmed
pubmed-article:12599241pubmed:articleTitleKi-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?lld:pubmed
pubmed-article:12599241pubmed:affiliationInternational Breast Cancer Study Group Pathology Center, Western Infirmary, Glasgow, United Kingdom.lld:pubmed
pubmed-article:12599241pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12599241pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12599241pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12599241lld:pubmed